Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


Med Ad News Insider

New FDA guidance offers risks/rewards for industry

Tuesday, January 20th, 2009

Earlier this month, FDA issued a final guidance on Good Reprint Practices, which will make it easier for pharmaceutical companies to advise doctors on unapproved uses of medicines.  The guidance sets out FDA's new thinking when it comes to the distribution of medical journal articles and scientific or medical reference ...